Canada markets open in 1 hour 37 minutes

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3516-0.0075 (-2.10%)
At close: 3:58PM EDT
Sign in to post a message.
  • J
    Jason
    Khiron has a higher share price then Pharmcielo now. Officially the top dawg now? i think so :)
  • R
    Robb
    We should get paid to read this forum. Khiron rules. They're still not diluting shares to raise cash or taking on debt. Hoping the patient count in Colombia continues to rise exponentially.
  • P
    Platinum
    BIZ = Paid basher. Paid per post. Paid to talk negatively about Khiron. The reason why this is obvious is because it's not possible to short a stock below $1.00. So the only motivation for @BIZ is the person that is paying this person to post. Probably $1.00-2.00 per post this person gets paid. BIZ spends many hours a day in this forum and other forums pertaining to Khiron for the past 6 months. There is no one in their right mind that would do this without gaining some benefit for spending these hours each day.
  • j
    jon
    1 million patients by 2024ColombiaBy leveraging its extensive network of patients and physicians, Khiron is driving toward exponential sales growth in Colombia. At its three wholly-owned clinics, Khiron has trained 40 medical cannabis specialists with expectations of issuing 1,000 prescriptions per week as new physicians are onboarded. As the company works to optimize processes and protocols, increasing patient access and convenience remains a top priority. Khiron is also committed to increasing third-party pharmacy distribution and recently announced a milestone agreement with Locatel pharmacies.PeruIn Peru, Khiron is close to achieving first sales, which would make it one of the first companies authorized to sell medical cannabis in the country of 32M. To date, Khiron has signed 2-year manufacturing and distribution agreements and received import license and all authorizations to commercialize high CBD full spectrum medical cannabis products. Sales are contingent on the receipt of a THC import quota and are forecast to start in Q3/20.BrazilWith a population of over 210M and a potential market size exceeding US$4.5B, Brazil represents the largest addressable market in Latin America. In January 2020, Brazil approved guidelines for the import of medical cannabis. The new regulatory framework provided Khiron with a unique opportunity to import its high and low-THC medical cannabis products to the country. To date, Khiron has obtained authorizations for compassionate care imports and entered into an exclusive agreement with Medlive, a leading marketer and distributor of pharmaceutical products in southern Brazil. Through this agreement, physicians in Medlive's extensive network will receive medical education and training related to Khiron products, allowing Khiron to market its medical cannabis products through Medlive's extensive network of doctor offices, clinics, hospitals and governmental institutions. The company expects to initially serve patients through compassionate care channels, with first sales planned for Q3/20.UKWith an eye on global expansion, Khiron became the exclusive Latin American company participating in Project Twenty21. Management believes the company?s participation in Europe?s 1st and largest national medical cannabis registry (which aims to enroll 20,000 patients by the end of 2021) will bolster Khiron?s credibility and commercial opportunities throughout Europe while generating significant revenues throughout the study. In Q2/20, Khiron issued its first high-THC medical prescriptions in the UK, a market which is projected to reach US$ 1.3B /year by 2024.GermanyOutside of North America, Germany is the largest medical cannabis market globally with a population of 82M and projected TAM of #$%$7.7B by 2028. On June 25, 2020, Khiron announced a distribution agreement with Nimbus Health, a leading medical cannabis distributor in Germany, with broad reach into domestic pharmacies. Medical education and marketing activities are expected to begin imminently with first sales expected in Q3/20.
  • S
    Slim
    Good time to load more!
  • j
    jon
    Photo by Obed Hernández via Unsplash
    CANNABIS IS COMING! THE LATEST ON COLOMBIA AND MEXICO
    FRED ROCAFORTSEPTEMBER 8, 2020
    In partnership with The Fresh Toast

    Columbia lawmakers say the regulated sales of cannabis could help counteract the negative economic impact of the COVID-19 pandemic.
    As many of our readers will know, the U.S. House of Representatives is set to vote on nationwide decriminalization of marijuana this month under the MORE Act. If legislators in Colombia and Mexico have their way, the House’s counterparts in two important Latin American economies could be following its steps.

    In Colombia, Reps. Juan Carlos Losada (Liberal – Bogota) and Juan Fernando Reyes (Liberal – Valle del Cauca) have introduced a bill to permit recreational cannabis use. Currently, Art. 49 of the Colombian Constitution prohibits the possession and consumption of narcotic or psychotropic substances. The bill would amend Art. 49 to exclude cannabis from its prohibitions.

    The bill’s sponsors are bold, not mincing words in the way many U.S. politicians do, even when they support legalization efforts. According to Losada, cannabis “is not a dangerous drug,” citing the World Health Organization. By contrast, even Washington State Gov. Jay Inslee (who has “earned top marks—an ‘A’ grade—from NORML“), stresses the need to “talk to kids about why marijuana isn’t safe.”

    RELATED: Mexico Just Legalized Marijuana In Historic Milestone

    Losada and Reyes argue in favor of legalization drawing from a range of arguments. One is economic, noting that regulated sales of cannabis could help counteract the negative economic impact of the COVID-19 pandemic.

    DEA Doesn't Want You To Worry About Its New Hemp Rule—Don’t Take the Bait!
    Photo by Olena Ruban/Getty Images
    In addition to tax proceeds, the country’s budget would benefit from savings on law enforcement activity relating to cannabis. They also point out that a legal market for cannabis would divert proceeds away from criminal syndicates, a consideration that is likely to resonate with many Colombians, given the country’s bloody struggles with drug cartels. In addition, legalization would facilitate research. The sponsors also highlight the implications for individual freedom of giving adult Colombians a choice when it comes to cannabis.

    RELATED: Border Woes: Transporting CBD Into Canada Is Not OK

    Meanwhile in Mexico, the Senate majority leader, Ricardo Monreal (MORENA – At-Large), announced cannabis legislation was “one of the priorities” of his parliamentary group once legislative sessions resume. His declarations came after his colleague Jesusa Rodríguez (MORENA – At-Large) brought a cannabis plant into the Senate chamber. The plant was a gift from members of the Mexican Cannabic Movement, who are engaged in an indefinite sit-in on Senate grounds in favor of cannabis legislation. According to Monreal, this was probably the first time a cannabis plant was brought into the Senate building
  • j
    ju
    I just check here once in a while now. Don?t care to read his #$%$ I?m on the sidelines until 2021. Not selling one share. Holding 67500 shares now
  • j
    jon
    recreational use coming to Colombia;

    In Colombia, Reps. Juan Carlos Losada (Liberal – Bogota) and Juan Fernando Reyes (Liberal – Valle del Cauca) have introduced a bill to permit recreational cannabis use. Currently, Art. 49 of the Colombian Constitution prohibits the possession and consumption of narcotic or psychotropic substances. The bill would amend Art. 49 to exclude cannabis from its prohibitions.
  • S
    Slim
    Lol BIZ
  • T
    Thomi
    Patience will result in many patients; from the todays Khiron Investors Newsletter (subscribe to it on their homepage) I quote; "...we issued our second 1,000 prescriptions in just 30 days, which was 4x faster than our first 1,000 prescriptions! We’re currently issuing 100 prescriptions every two days ..." That's called exponential growth and the real game has not even yet started...

    People looking for quick wins; leave, don't buy shares, buy a toy. If you don't like the story, don't buy the stock, buy maybe a drink and leave the others do what they want. Either you believe in it and then yes buy the stock and stick to it for the long run say 3-5 years - everything else doesn't make sense or you didn't understand what a share investment is especially in a new emerging industry or basically a "start-up". I am in for the long game. Good luck
  • B
    Bernard
    After a year in this forum, BIZ still doesn't understand why a "Start Up" doesn't have revenue before they start up with sales of their products. He is either very slow and or just using the revenue talking point over and over because he has no legitimate arguments. In Biz's mind a production company should have massive revenue before they build their factories and start production, a tech company should have massive revenue before they monetize their platform, a medical company should have massive revenue on the drugs which are in the testing phase and have not yet been approved. BIZ, you got to understand dow ignorant you sound, right?
  • j
    jon
    Rappi has an average of more than 10 million active users monthly, according to research firm Apptopia, providing deliveries for almost 100,000 businesses in LatAm, including over 13 million deliveries in Colombia alone. Beyond a standard vendor agreement, this expanded partnership introduces the Company's CBD-based Wellbeing products to millions of Rappi users across Latin America through its sophisticated technology and advanced, customer-centric marketing strategies.
  • P
    Platinum
    Khiron stock price needs proof of revenues rising. They told us when they hit their first 1000 patients, I feel they are going to deliver to us very soon the next milestone on patients increasing. Until we can start showing these revenues in the quarterly reports, this is how they are going to have to share with investors that revenues are rising.
  • j
    jon
    Columbia lawmakers say the regulated sales of cannabis could help counteract the negative economic impact of the COVID-19 pandemic.
  • j
    jon
    technical charts show we are pulling out of almost 3 months of negative momentum and we are begging to break through resistance trend lines on the 5 and 10 day charts; looks like we are building up to a breakout in SP
  • j
    jon
    Khiron Life Sciences – which has cultivation and manufacturing operations in Colombia – expects to start sales in Peru this month.

    The Toronto-based company’s subsidiary in Peru is already licensed to import cannabis.

    Khiron secured an exclusive agreement with Peruvian Farmacia Universal for the pharmacy chain to dispense the company’s products as magistral preparations. Luis Márquez, Khiron’s country manager in Peru, told MJBizDaily that the plan is to start selling the company’s products to patients in September.

    “From a regulatory point of view, everything needed is already in place both from the Peruvian and Colombian side,” Márquez said.

    “The only thing that’s missing is to ship the product from Colombia to Peru, and once it arrives, we can start selling through Farmacia Universal right away.”

    According to Márquez, one of Farmacia Universal’s retail locations has already been approved to dispense medical cannabis, but the pharmacy chain is applying for more of its retail locations to get the needed authorization.

    we about to take off yall;
  • T
    Thomi
    This is gonna be a 2, 3 or more billion market cap company in 5 years. It is NOT going to happen over night but over time will grow nicely. LatAm is huge and is not as overcrowded like Canada or the US, UK Twenty2021 is a nice start and more in the pipeline, Mexican University as a partner to "educate" doctors is a great platform too. Patience is needed but this is the case with any new emerging industry. The doubters and negative people are out there as usual, Pharma lobby with deep pockets fearing some competitions regarding painkiller or anti-inflammatory medications but the time will come.... as the train has left the station, it is still slow but goes steadily and picks up speed.... so Pharma at some point will enter the market to "compensate" and participate in this new business... better to get a share of it instead of just losing in other medication sales....
  • j
    jon
    in Mexico, the Senate majority leader, Ricardo Monreal (MORENA – At-Large), announced cannabis legislation was “one of the priorities” of his parliamentary group once legislative sessions resume. His declarations came after his colleague Jesusa Rodríguez (MORENA – At-Large) brought a cannabis plant into the Senate chamber. The plant was a gift from members of the Mexican Cannabic Movement, who are engaged in an indefinite sit-in on Senate grounds in favor of cannabis legislation. According to Monreal, this was probably the first time a cannabis plant was brought into the Senate building
  • j
    jon
    Khiron Peru is a GSP certified, registered pharmaceutical establishment, and Farmacia Universal has all required permits, including Good Manufacturing Practices (GMP) certification, to distribute medical cannabis final products to patients through pharmacies under the previously announced agreement with Khiron.
  • S
    Slim
    Medical marijuana companies seeking to serve patients in Peru have been stymied by government red tape, but that appears to be slowly changing with a handful of products poised to begin trickling into the Andean country.
    Medical marijuana companies seeking to serve patients in Peru have been stymied by government red tape, but that appears to be slowly changing with a handful of products poised to begin trickling into the Andean country.
    mjbizdaily.com